Oncofetal protein IMP3, a new cancer biomarker
- PMID: 24713990
- DOI: 10.1097/PAP.0000000000000021
Oncofetal protein IMP3, a new cancer biomarker
Abstract
IMP3 is a member of a family of RNA-binding proteins that consists of IMP1, IMP2 and IMP3. These proteins contain 2 RNA recognition motifs and 4 K-homology domains that allow them to bind RNAs strongly and specifically. IMP3 is an oncofetal protein involved in embryogenesis and its expression is associated with a number of malignant neoplasms. IMP3 is associated with aggressive and advanced cancers and is specifically expressed in malignant tumors but is not found in adjacent benign tissues. Moreover, in vitro studies have shown that IMP3 promotes tumor cell proliferation, adhesion, and invasion. This review focuses on the studies of IMP3 expression in different cancers and emphasizes the potential utility of IMP3 in routine surgical pathology practice. We also discuss IMP3 as a prognostic biomarker for cancer patients' outcomes.
Similar articles
-
Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma.Hum Pathol. 2012 Oct;43(10):1567-72. doi: 10.1016/j.humpath.2011.12.020. Epub 2012 Apr 10. Hum Pathol. 2012. PMID: 22497850
-
Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma.Hum Pathol. 2013 Oct;44(10):2126-31. doi: 10.1016/j.humpath.2013.04.002. Epub 2013 Jun 25. Hum Pathol. 2013. PMID: 23806529
-
Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.Biotech Histochem. 2012 Jan;87(1):24-9. doi: 10.3109/10520295.2011.591831. Epub 2011 Aug 15. Biotech Histochem. 2012. PMID: 21838610 Review.
-
Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.Ann Surg Oncol. 2009 Jun;16(6):1711-9. doi: 10.1245/s10434-009-0446-0. Epub 2009 Apr 9. Ann Surg Oncol. 2009. PMID: 19357927
-
IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.Genes Dev. 2016 Nov 15;30(22):2459-2474. doi: 10.1101/gad.287540.116. Genes Dev. 2016. PMID: 27940961 Free PMC article. Review.
Cited by
-
A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma.Int J Biol Sci. 2019 Aug 22;15(11):2282-2295. doi: 10.7150/ijbs.32899. eCollection 2019. Int J Biol Sci. 2019. PMID: 31595147 Free PMC article.
-
Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.J Immunol. 2018 Apr 1;200(7):2263-2279. doi: 10.4049/jimmunol.1700242. Epub 2018 Feb 26. J Immunol. 2018. PMID: 29483360 Free PMC article.
-
Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients.Mol Med. 2020 Dec 9;26(1):125. doi: 10.1186/s10020-020-00252-5. Mol Med. 2020. PMID: 33297932 Free PMC article.
-
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.Int J Mol Sci. 2024 Jan 19;25(2):1251. doi: 10.3390/ijms25021251. Int J Mol Sci. 2024. PMID: 38279253 Free PMC article. Review.
-
IMP3 Expression as a Potential Tumour Marker in High-Risk Localisations of Cutaneous Squamous Cell Carcinoma: IMP3 in Metastatic cSCC.Cancers (Basel). 2023 Aug 14;15(16):4087. doi: 10.3390/cancers15164087. Cancers (Basel). 2023. PMID: 37627115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous